NYSE: OWLTOwlet Inc Stock
$5.08-0.11 (-2.12%)
Updated Apr 28, 2026
OWLT Price
$5.08
Fair Value Price
N/A
Market Cap
$143.06M
52 Week Low
$3.78
52 Week High
$16.94
P/E
-2.2x
P/B
7.51x
P/S
2.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$105.71M
Earnings
-$39.68M
Gross Margin
50.6%
Operating Margin
-34.28%
Profit Margin
-39.6%
Debt to Equity
2.64
Operating Cash Flow
-$11M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OWLT Overview
Sandbridge Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Los Angeles, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OWLT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
OWLT
Ranked#44 of 45
Ranked#44 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.40 | A | |
| $3.18 | B | |
| $47.49 | B |
Be the first to know about important OWLT news, forecast changes, insider trades & much more!
OWLT News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OWLT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OWLT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OWLT is poor value based on its book value relative to its share price (7.51x), compared to the US Health Information Services industry average (2.93x)
P/B vs Industry Valuation
OWLT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OWLT due diligence checks available for Premium users.
Valuation
OWLT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.2x
Industry
29.37x
Market
31.26x
OWLT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.51x
Industry
2.93x
OWLT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OWLT's financial health
Profit margin
Revenue
$26.6M
Net Income
-$9.2M
Profit Margin
-37.3%
OWLT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
OWLT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$85.6M
Liabilities
$50.2M
Debt to equity
2.64
OWLT's short-term assets ($81.92M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OWLT's short-term assets ($81.92M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OWLT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OWLT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$452.0k
Investing
-$489.0k
Financing
$17.9M
OWLT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OWLT vs Health Information Service Stocks
Owlet Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.